Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab

Figure 1

Clinical time course for a non-small-cell lung cancer patient treated with trastuzumab. The time course for disease and treatment and the results of performed genetic testing are shown starting from the time of diagnosis. Abbreviations: NGS: next-generation sequencing; WBRT: whole brain radiotherapy.